Skip to main content
LobbyMap

Merck & Co

Pharmaceutical & Health Products · Lobbying Client

B
Influence Score
66/100
High Influence
$27.3M
Total Lobby Spend
7
Policy Issues
10
Lobbyists
3
Revolving Door

Merck & Co reported $27.3 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 7 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Centers for Medicare & Medicaid Services
Small Business Administration
US Senate
US House of Representatives
Dept of Transportation
National Science Foundation
Dept of Energy
Dept of Commerce

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2020 Jan-MarCovington & Burling LLP
GOV
4$1.2M
2020 Apr-JunCassidy & Associates LLP
TAXPHACPT
4$1.7M
2020 Jul-SepAkin Gump LLP
HCRPHAMED
3$1.3M
2020 Oct-DecCassidy & Associates LLP
TAXTRDHCR+2
3$1.4M
2021 Jan-MarCassidy & Associates LLP
CPTPHAHCR+1
3$1.6M
2021 Apr-JunCassidy & Associates LLP
MEDHCR
3$1.2M
2021 Jul-SepK&L Gates LLP
HCR
1$1.3M
2021 Oct-DecK&L Gates LLP
PHAMEDHCR+2
2$1.4M

Merck & Co Lobbying FAQ

Merck & Co has spent $27.3M on federal lobbying across 7 policy areas. This includes spending on registered lobbyists and direct government contacts.

Merck & Co lobbies on 7 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Copyright/Patent/Trademark. These disclosures are filed quarterly with the Senate Office of Public Records.

Merck & Co has an Influence Score of 66/100 (Grade B). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Merck & Co employs 10 registered lobbyists, of whom 3 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

Merck & Co has contacted 8 government entities as part of their lobbying activities, including Centers for Medicare & Medicaid Services, Small Business Administration, US Senate.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.